WallStSmart

Sensata Technologies Holding NV (ST)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Sensata Technologies Holding NV generates 1340% more annual revenue ($3.73B vs $258.90M). ST leads profitability with a 1.3% profit margin vs -15.5%. ST earns a higher WallStSmart Score of 59/100 (C).

ST

Buy

59

out of 100

Grade: C

Growth: 4.7Profit: 5.5Value: 7.3Quality: 6.8
Piotroski: 3/9

ZEPP

Hold

38

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

STUndervalued (+41.6%)

Margin of Safety

+41.6%

Fair Value

$63.72

Current Price

$45.75

$17.97 discount

UndervaluedFair: $63.72Overvalued
ZEPPUndervalued (+48.9%)

Margin of Safety

+48.9%

Fair Value

$46.96

Current Price

$18.01

$28.95 discount

UndervaluedFair: $46.96Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ST4 strengths · Avg: 9.0/10
PEG RatioValuation
0.2510/10

Growing faster than its price suggests

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

EPS GrowthGrowth
25.5%8/10

Earnings expanding 25.5% YoY

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

ST4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Return on EquityProfitability
1.7%3/10

ROE of 1.7% — below average capital efficiency

Profit MarginProfitability
1.3%3/10

1.3% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

ZEPP4 concerns · Avg: 2.3/10
Market CapQuality
$270.28M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Free Cash FlowQuality
$-26.48M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : ST

The strongest argument for ST centers on PEG Ratio, Debt/Equity, Price/Book. PEG of 0.25 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : ST

The primary concerns for ST are Revenue Growth, Return on Equity, Profit Margin. A P/E of 127.8x leaves little room for execution misses. Thin 1.3% margins leave little buffer for downturns.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

ST profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

ST generates stronger free cash flow (105M), providing more financial flexibility.

Bottom Line

ST scores higher overall (59/100 vs 38/100). ZEPP offers better value entry with a 48.9% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Sensata Technologies Holding NV

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Sensata Technologies Holding plc, develops, manufactures and sells sensors, sensor-based solutions, controls and other products in America, Europe, Asia and internationally. The company is headquartered in Attleboro, Massachusetts.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?